Ascend Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ascend Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-39,216	Closed	-$5.18M	–	288
2017 Q4	$5.18M	Sell	39,216 -21,834	-36%	-$2.57M	0.19%	117
2017 Q3	$6.2M	Buy	+61,050	New	+$6.54M	0.23%	101
2015 Q4	–	Sell	-24,960	Closed	-$2.28M	–	180
2015 Q3	$2.28M	Buy	+24,960	New	+$2.78M	0.09%	108

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ascend Capital's GWPH Position: Q1 2018 in Review

Ascend Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 39,216 shares — an estimated $5.18M sold.

Ascend Capital first reported a position in GWPH in Q3 2015 and held it in 3 quarters. The position peaked at $6.2M in Q3 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

Ascend Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 39,216 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $5.18M.
Ascend Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 3 quarters.
Ascend Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.2M in Q3 2017.
191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.